Wellington Management Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,979,844
| Closed | -$47.8M | – | 1816 |
|
|
2023
Q3 | $47.8M | Sell |
6,979,844
-658,024
| -9% | -$4.51M | 0.01% | 703 |
|
|
2023
Q2 | $79.2M | Buy |
7,637,868
+265,267
| +4% | +$2.75M | 0.02% | 601 |
|
|
2023
Q1 | $59.6M | Buy |
7,372,601
+1,888,588
| +34% | +$15.3M | 0.01% | 650 |
|
|
2022
Q4 | $86.4M | Buy |
5,484,013
+2,030,160
| +59% | +$32M | 0.02% | 557 |
|
|
2022
Q3 | $54.4M | Sell |
3,453,853
-1,447,410
| -30% | -$22.8M | 0.01% | 651 |
|
|
2022
Q2 | $68.4M | Sell |
4,901,263
-828,990
| -14% | -$11.6M | 0.01% | 611 |
|
|
2022
Q1 | $98.8M | Buy |
5,730,253
+190,985
| +3% | +$3.29M | 0.02% | 584 |
|
|
2021
Q4 | $80.5M | Buy |
5,539,268
+118,815
| +2% | +$1.73M | 0.01% | 688 |
|
|
2021
Q3 | $97.6M | Buy |
5,420,453
+722,704
| +15% | +$13M | 0.02% | 633 |
|
|
2021
Q2 | $82.5M | Buy |
4,697,749
+3,866,420
| +465% | +$67.9M | 0.01% | 686 |
|
|
2021
Q1 | $21M | Buy |
+831,329
| New | +$21M | ﹤0.01% | 1060 |
|
|
2018
Q2 | – | Sell |
-32,894
| Closed | -$577K | – | 2218 |
|
|
2018
Q1 | $577K | Buy |
+32,894
| New | +$577K | ﹤0.01% | 1994 |
|